Showing results (421-430 of 591) with videos related to

Sort By:
Pageof 60
Cancer|May 10, 2005
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parametersBurcak Vural, Lin-Chi Chen, Pinar Saip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastasesZsuzsanna Varga, Jean-Philippe Theurillat, Valeriy Filonenko, et al.
The Analyst|October 8, 2016
Rapid infrared mapping for highly accurate automated histology in Barrett's oesophagusO J Old, G R Lloyd, J Nallala, et al.
Biotechnology Progress|March 3, 2011
Expression and purification of cGMP grade NY-ESO-1 for clinical trialsAdam J Lowe, Cameron L Bardliving, Chung-Jr Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu miceS Welt, M J Mattes, R Grando, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphomaM S Czuczman, D J Straus, C R Divgi, et al.
Cancer Research|December 1, 1989
Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomasN H Bander, C L Finstad, C Cordon-Cardo, et al.
International Journal of Cancer|July 13, 2002
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissuesAchim A Jungbluth, Yao-Tseng Chen, Klaus J Busam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblastsS Welt, C R Divgi, A M Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 10, 2004
Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancerChaitanya R Divgi, Joseph A O'Donoghue, Sydney Welt, et al.
Pageof 60